Stockscreener 앱 받기
35.35
1.06%
0.385
전일 마감가:
$34.97
열려 있는:
$35.86
하루 거래량:
290.04K
Relative Volume:
0.26
시가총액:
$4.39B
수익:
$418.33M
순이익/손실:
$-252.07M
주가수익비율:
-14.73
EPS:
-2.4
순현금흐름:
$-238.84M
1주 성능:
-5.96%
1개월 성능:
+17.25%
6개월 성능:
+34.94%
1년 성능:
+104.40%
1일 변동 폭
$35.01
$36.00
1주일 범위
$34.55
$37.10
52주 변동 폭
$16.01
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
4560 JINKE ROAD, SHANGHAI
ZLAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
35.30 | 4.39B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.05 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
538.55 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.20 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
550.42 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.06 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Metric Deep Dive: Understanding Winnebago Industries, Inc (WGO) Through its Ratios - DWinneX
Zai Lab Limited ADR (ZLAB) Stock: A Year of Stock Market Dynamics - investchronicle.com
Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st
Zai Lab Limited ADR (ZLAB) Stock: Uncovering 52-Week Market Trends - investchronicle.com
CarParts.com Inc (PRTS) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize
Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Two Sigma Investments LP Trims Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Two Sigma Advisers LP Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Bank of America Corp DE Has $1.63 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - MSN
Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus
Zai Lab Limited (NASDAQ:ZLAB) Sees Large Drop in Short Interest - Defense World
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance
What Analysts Were Expecting After Zai Lab Limited ADR (NASDAQ: ZLAB) fell -3.74% - Stocksregister
Zai Lab Announces Participation in Investor Conferences in June 2025 - BioSpace
Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan
Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Quantinno Capital Management LP Reduces Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
BNP Paribas Financial Markets Purchases 18,472 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace
Barclays PLC Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Cantor Fitzgerald Expects Increased Earnings for Zai Lab - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus
Trading Day Triumph: Zai Lab Limited ADR (ZLAB) Ends at 29.38, a -5.07 Surge/Plunge - DWinneX
Raymond James Financial Inc. Makes New $1.03 Million Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Invesco Ltd. - Defense World
Envestnet Asset Management Inc. Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Geode Capital Management LLC Boosts Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Post-Trade Analysis: VICI Properties Inc (VICI) Climbs 0.06, Closing at 32.26 - DWinneX
Market Insights: Canadian Solar Inc (CSIQ)’s Notable Drop of -1.73, Closing at 9.65 - DWinneX
Daily Market Movement: Faraday Future Intelligent Electric Inc (FFAI) Sees a -0.76 Decrease, Closing at 1.30 - DWinneX
In the Green: Zai Lab Limited ADR (ZLAB) Closes at 31.84, Up/Down -1.82 from Previous Day - DWinneX
Closing Bell Recap: C.H. Robinson Worldwide, Inc (CHRW) Ends at 88.33, Reflecting a -0.84 Downturn - DWinneX
Zai Lab Limited ADR (ZLAB) is looking forward to a strong quarter - Sete News
Wells Fargo & Company MN Grows Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Ltd Announces 2025 Annual General Meeting - TipRanks
Zai Lab Limited ADR (ZLAB) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025 - Business Wire
Ratios Reveal: Breaking Down Packaging Corp Of America (PKG)’s Financial Health - DWinneX
Analytical Overview: GE Vernova Inc (GEV)’s Ratios Tell a Financial Story - DWinneX
Financial Health Check: Examining Bellring Brands Inc (BRBR)’s Key Ratios - DWinneX
Deeper Dive: Understanding Concentrix Corp (CNXC) Through its Various Ratios - DWinneX
A stock that deserves closer examination: Zai Lab Limited ADR (ZLAB) - uspostnews.com
Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX
Ratios Reveal: Breaking Down Check Point Software Technologies Ltd (CHKP)’s Financial Health - DWinneX
Financial Metrics Unveiled: Orchestra BioMed Holdings Inc (OBIO)’s Key Ratios in the Spotlight - DWinneX
Ratios in Focus: Analyzing Watsco Inc (WSO)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Theratechnologies Inc (THTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Zai Lab Limited Adr 주식 (ZLAB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Du Ying | Chairperson & CEO |
Jun 26 '25 |
Sale |
36.13 |
23,669 |
855,208 |
514,982 |
| Chen Yajing | Chief Financial Officer |
Jun 26 '25 |
Sale |
36.13 |
2,675 |
96,653 |
21,004 |
0.61%
0.91%
자본화:
|
볼륨(24시간):